Skip to content
Screener

CG Oncology CGON Total debt

Total debt at other companies

Pfizer logo
PfizerPFE
$64.43B+4.9%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$49.04B-3.4%
Gilead Sciences logo
Gilead SciencesGILD
$26.25B+5.2%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$445.39M+32.2%
Aura Biosciences, Inc. logo
Aura Biosciences, Inc.AURA
$16.99M-7.9%
UroGen Pharma logo
UroGen PharmaURGN
$197.54M+55.0%

Other financials

Income statement

See full
Revenue$1.2M
Operating income-$86.4M-77.3%
Net income-$79.1M-90.8%
EPS (diluted)-$0.90-66.7%

Balance sheet

See full
Cash & equivalents$19.6M+34.3%
Total equity$1.0B+53.5%
Total assets$1.1B+54.8%

Cash flow

See full
Operating cash flow-$46.4M-66.0%
CapEx$468.0K+3,243%
Free cash flow-$46.9M-67.6%

Valuation

See full
Market cap$6.6B+242%
Enterprise value$6.59B+244%
P/S1,060×-2,439×

Profitability

See full
Operating margin-4,056.2%-1,873pp
Net margin-3,602.7%-1,650pp
FCF margin-2,879.6%-1,307pp

Returns & leverage

See full
Return on equity-26.4%+9.3pp
Debt / equity0.0×
Current ratio22.2×+0.1×

Where this comes from

Calculated from CG Oncology’s reported figures.

Plus components not separately reported this period.

The source filing: CG Oncology’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 8:45 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-336918

FAQ

What is CG Oncology's total debt?
CG Oncology (CGON) reported total debt of $8.82M in Q2 2026.
How has CG Oncology's total debt changed year-over-year?
CG Oncology's total debt increased by 787.2% year-over-year, from $994K to $8.82M.
What is the long-term trend for CG Oncology's total debt?
Over 2 years (2023 to 2025), CG Oncology's total debt has grown at a 290.3% compound annual growth rate (CAGR), from $461K to $7.02M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.

Ask your AI about CG Oncology's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude